Variant name,Rx name,#Published
N501Y,CP,148
N501Y,IP,106
N501Y,mAbs phase3,51
N501Y,mAbs structure,17
E484K,CP,90
E484K,IP,47
E484K,mAbs phase3,58
E484K,mAbs structure,17
Other individual mutations,CP,616
Other individual mutations,IP,466
Other individual mutations,mAbs phase3,652
Other individual mutations,mAbs structure,489
All individual mutations,CP,854
All individual mutations,IP,611
All individual mutations,mAbs phase3,752
All individual mutations,mAbs structure,521
B.1.1.7,CP,442
B.1.1.7,IP,431
B.1.1.7,mAbs phase3,66
B.1.1.7,mAbs structure,28
B.1.351,CP,416
B.1.351,IP,267
B.1.351,mAbs phase3,64
B.1.351,mAbs structure,20
P.1,CP,111
P.1,IP,127
P.1,mAbs phase3,28
P.1,mAbs structure,5
CAL.20C,CP,32
CAL.20C,IP,37
CAL.20C,mAbs phase3,3
CAL.20C,mAbs structure,0
B.1.526,CP,0
B.1.526,IP,0
B.1.526,mAbs phase3,3
B.1.526,mAbs structure,0
Other muation combinations,CP,588
Other muation combinations,IP,472
Other muation combinations,mAbs phase3,172
Other muation combinations,mAbs structure,160
All combinations of mutations,CP,1589
All combinations of mutations,IP,1342
All combinations of mutations,mAbs phase3,345
All combinations of mutations,mAbs structure,215
